Oncoscope-AI is now available on iPad
Request free access to get started

The Market Access Podcast: Will AI and Living Reviews Define the Next Era of Health Care Market Access?

Will AI and Living Reviews Define the Next Era of Health Care Market Access?

Oncoscope-AI Founder & CEO Anna Forsythe was recently on the Market Access Podcast with Dr. Stefan Walzer to discuss how Living Systematic Literature Reviews (Living SLRs) are redefining evidence generation in oncology and beyond – highlighting the power of real-time updates, advanced automation, and the essential role of human insight.

Traditional SLRs are static snapshots, while Living SLRs are real-time, dynamic, and AI-powered—delivering continuously updated insights crucial for life-or-death decisions and payer evaluations. Join this discussion as they explore the myth of AI chatbots as true decision support tools, the need for actionable data over summaries, and the future of evidence synthesis, clinical decision-making, and smarter market access.

Listen on Spotify:

Listen on YouTube:

Listen on PocketCasts:

Recent posts

Why AI’s Biggest Blind Spot In Pharma Isn’t Technical by Anna Forsythe for Forbes
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical
Pharma’s Biggest Missed AI Opportunity Is Living Evidence
Pharma’s Biggest Missed AI Opportunity Is Living Evidence
Introducing REAL-SLR: REal-Time, AI-Supported Living Systematic Literature Review
Oncoscope-AI Launches REAL-SLR library to Transform Oncology Evidence supporting Pharma R&D and Market Access Decisions

Login

Essential

Log in to the Oncoscope-AI Essential platform.

Edge

Log in to the Oncoscope-AI Edge platform.